Literature DB >> 6094411

Quinocarcin, a novel antitumor antibiotic. 3. Mode of action.

F Tomita, K Takahashi, T Tamaoki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094411     DOI: 10.7164/antibiotics.37.1268

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  6 in total

Review 1.  Natural products synthesis: enabling tools to penetrate Nature's secrets of biogenesis and biomechanism.

Authors:  Robert M Williams
Journal:  J Org Chem       Date:  2011-04-12       Impact factor: 4.354

2.  Antitumor activities of KW-2152, a new isoquinon agent, against human tumor xenografts transplanted into nude mice.

Authors:  Y Nosoh; M Nishiyama; K Niimi; N Hirabayashi; T Toge; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1987-03

3.  Computer simulation of the binding of quinocarcin to DNA. Prediction of mode of action and absolute configuration.

Authors:  G C Hill; T P Wunz; W A Remers
Journal:  J Comput Aided Mol Des       Date:  1988-07       Impact factor: 3.686

4.  The mechanism of action of quinocarmycin citrate (KW 2152) on mouse L1210 cells in vitro.

Authors:  R Kanamaru; Y Konishi; C Ishioka; H Kakuta; T Sato; A Ishikawa; M Asamura; A Wakui
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

5.  Analogs of tetrahydroisoquinoline natural products that inhibit cell migration and target galectin-3 outside of its carbohydrate-binding site.

Authors:  Alem W Kahsai; Junru Cui; H Umit Kaniskan; Philip P Garner; Gabriel Fenteany
Journal:  J Biol Chem       Date:  2008-06-13       Impact factor: 5.157

6.  Asymmetric one-pot synthesis of 1,3-oxazolidines and 1,3-oxazinanes via hemiaminal intermediates.

Authors:  Sri Krishna Nimmagadda; Zuhui Zhang; Jon C Antilla
Journal:  Org Lett       Date:  2014-07-30       Impact factor: 6.005

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.